268 related articles for article (PubMed ID: 21210153)
21. Clinical manifestation and molecular genetic characterization of MYH9 disorders.
Provaznikova D; Geierova V; Kumstyrova T; Kotlin R; Mikulenkova D; Zurkova K; Matoska V; Hrachovinova I; Rittich S
Platelets; 2009 Aug; 20(5):289-96. PubMed ID: 19557653
[TBL] [Abstract][Full Text] [Related]
22. A De Novo Mutation in MYH9 in a Child With Severe and Prolonged Macrothrombocytopenia.
Li K; Jin R; Xu W; Shen Y; Lu K; Wu X
J Pediatr Hematol Oncol; 2021 Jan; 43(1):e7-e10. PubMed ID: 32520844
[TBL] [Abstract][Full Text] [Related]
23. Perioperative management of MYH9 hereditary macrothrombocytopenia (Fechtner syndrome).
Selleng K; Lubenow LE; Greinacher A; Warkentin TE
Eur J Haematol; 2007 Sep; 79(3):263-8. PubMed ID: 17655694
[TBL] [Abstract][Full Text] [Related]
24. Immunocytochemistry for the heavy chain of the non-muscle myosin IIA as a diagnostic tool for MYH9-related disorders.
Pecci A; Noris P; Invernizzi R; Savoia A; Seri M; Ghiggeri GM; Sartore S; Gangarossa S; Bizzaro N; Balduini CL
Br J Haematol; 2002 Apr; 117(1):164-7. PubMed ID: 11918549
[TBL] [Abstract][Full Text] [Related]
25. R705H mutation of MYH9 is associated with MYH9-related disease and not only with non-syndromic deafness DFNA17.
Verver E; Pecci A; De Rocco D; Ryhänen S; Barozzi S; Kunst H; Topsakal V; Savoia A
Clin Genet; 2015 Jul; 88(1):85-9. PubMed ID: 24890873
[TBL] [Abstract][Full Text] [Related]
26. Haematological characteristics of MYH9 disorders due to MYH9 R702 mutations.
Kunishima S; Yoshinari M; Nishio H; Ida K; Miura T; Matsushita T; Hamaguchi M; Saito H
Eur J Haematol; 2007 Mar; 78(3):220-6. PubMed ID: 17241369
[TBL] [Abstract][Full Text] [Related]
27. MYH9-related disease: a novel prognostic model to predict the clinical evolution of the disease based on genotype-phenotype correlations.
Pecci A; Klersy C; Gresele P; Lee KJ; De Rocco D; Bozzi V; Russo G; Heller PG; Loffredo G; Ballmaier M; Fabris F; Beggiato E; Kahr WH; Pujol-Moix N; Platokouki H; Van Geet C; Noris P; Yerram P; Hermans C; Gerber B; Economou M; De Groot M; Zieger B; De Candia E; Fraticelli V; Kersseboom R; Piccoli GB; Zimmermann S; Fierro T; Glembotsky AC; Vianello F; Zaninetti C; Nicchia E; Güthner C; Baronci C; Seri M; Knight PJ; Balduini CL; Savoia A
Hum Mutat; 2014 Feb; 35(2):236-47. PubMed ID: 24186861
[TBL] [Abstract][Full Text] [Related]
28. Association of a novel in-frame deletion mutation of the MYH9 gene with end-stage renal failure: case report and review of the literature.
Ishida M; Mori Y; Ota N; Inaba T; Kunishima S
Clin Nephrol; 2013 Sep; 80(3):218-22. PubMed ID: 22541678
[TBL] [Abstract][Full Text] [Related]
29. Pathogenetic mechanisms of hematological abnormalities of patients with MYH9 mutations.
Pecci A; Canobbio I; Balduini A; Stefanini L; Cisterna B; Marseglia C; Noris P; Savoia A; Balduini CL; Torti M
Hum Mol Genet; 2005 Nov; 14(21):3169-78. PubMed ID: 16162639
[TBL] [Abstract][Full Text] [Related]
30. MYH9 Associated nephropathy.
Furlano M; Arlandis R; Venegas MDP; Novelli S; Crespi J; Bullich G; Ayasreh N; Remacha Á; Ruiz P; Lorente L; Ballarín J; Matamala A; Ars E; Torra R
Nefrologia (Engl Ed); 2019; 39(2):133-140. PubMed ID: 30471777
[TBL] [Abstract][Full Text] [Related]
31. Familial cases with MYH9 disorders caused by MYH9 S96L mutation.
Murayama S; Akiyama M; Namba H; Wada Y; Ida H; Kunishima S
Pediatr Int; 2013 Feb; 55(1):102-4. PubMed ID: 23409987
[TBL] [Abstract][Full Text] [Related]
32. High-resolution melting analysis for detection of MYH9 mutations.
Provaznikova D; Kumstyrova T; Kotlin R; Salaj P; Matoska V; Hrachovinova I; Rittich S
Platelets; 2008 Sep; 19(6):471-5. PubMed ID: 18925516
[TBL] [Abstract][Full Text] [Related]
33. Late onset and high-frequency dominant hearing loss in a family with MYH9 disorder.
Wasano K; Matsunaga T; Ogawa K; Kunishima S
Eur Arch Otorhinolaryngol; 2016 Nov; 273(11):3547-3552. PubMed ID: 26942920
[TBL] [Abstract][Full Text] [Related]
34. MYH9 disorder: Identification and a novel mutation in patients with macrothrombocytopenia.
Natesirinilkul R; Sosothikul D; Komwilaisak P; Pongtanakul B; Narkbunnum N; Yudhasompop N; Mekjarusgool P; Niparuck P; Boonyawat K; Kunishima S; Sirachainan N;
Pediatr Blood Cancer; 2021 Jul; 68(7):e29055. PubMed ID: 33855781
[TBL] [Abstract][Full Text] [Related]
35. Macrothrombocytopenia With Döhle Body-Like Granulocyte Inclusions: A Case Report of May-Hegglin Anomaly in a 33-Year-Old White Woman With an Update on the Molecular Findings of MYH9-Related Disease.
Ruhoy SM; Yates A
Lab Med; 2016 Aug; 47(3):246-50. PubMed ID: 27353381
[TBL] [Abstract][Full Text] [Related]
36. COL4A5-associated X-linked Alport syndrome in a female patient with early inner ear deafness due to a mutation in MYH9.
Strasser K; Hoefele J; Bergmann C; Büscher AK; Büscher R; Hoyer PF; Weber S
Nephrol Dial Transplant; 2012 Nov; 27(11):4236-40. PubMed ID: 23144074
[TBL] [Abstract][Full Text] [Related]
37. MYH9 related platelet disorders - often unknown and misdiagnosed.
Althaus K; Najm J; Greinacher A
Klin Padiatr; 2011 May; 223(3):120-5. PubMed ID: 21567368
[TBL] [Abstract][Full Text] [Related]
38. Congenital thrombocytopenia with nephritis - The first case of MYH9 related disorder in Serbia.
Kuzmanović M; Kunishima S; Putnik J; Stajić N; Paripović A; Bogdanović R
Vojnosanit Pregl; 2014 Apr; 71(4):395-8. PubMed ID: 24783421
[TBL] [Abstract][Full Text] [Related]
39. Establishment of mouse model of MYH9 disorders: heterozygous R702C mutation provokes macrothrombocytopenia with leukocyte inclusion bodies, renal glomerulosclerosis and hearing disability.
Suzuki N; Kunishima S; Ikejiri M; Maruyama S; Sone M; Takagi A; Ikawa M; Okabe M; Kojima T; Saito H; Naoe T; Matsushita T
PLoS One; 2013; 8(8):e71187. PubMed ID: 23976996
[TBL] [Abstract][Full Text] [Related]
40. CKD in MYH9-related disorders.
Singh N; Nainani N; Arora P; Venuto RC
Am J Kidney Dis; 2009 Oct; 54(4):732-40. PubMed ID: 19726116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]